Gain Therapeutics, Inc. (NASDAQ:GANX) IPO

Gain Therapeutics, Inc.

IPO

Priced at US$11.00 a share on Mar 17, 2021.

Price
US$11.00 a share
Shares offered
3,636,364 shares of common stock
Offering size
US$40 million
Underwriters' option
Up to 545,454 more shares
Listing
GANX on the Nasdaq Global Market
Underwriters
BTIG, Oppenheimer & Co., National Securities Corporation · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceNov 16, 2020
Filed publiclyFeb 19, 2021
Amended twiceNewest Mar 15, 2021
Shares registered with an exchangeMar 17, 2021
Declared effective by the SECMar 17, 2021
Final prospectus, with the priceMar 22, 2021

From the cover of the final prospectus (424B4) filed Mar 22, 2021